en · de · es · pt
assay-notes.peptides4800.com › Guide › Background And Peptide Identity — Practical Notes

Background And Peptide Identity — Practical Notes

By Editorial Desk · published 2026-06-27 · last reviewed 2026-07-11 · Guide

The short version of Heptapeptide fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-07-11. Anything still debated is marked as such rather than presented as settled.

Background and Peptide Identity

Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.

Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.

Administration, Testing and Availability

Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.

Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.

Selank at a glance

PropertyValueNotes
Chemical classSynthetic heptapeptideModeled on tuftsin
Amino acid sequenceThr-Lys-Pro-Arg-Pro-Gly-ProSeven residues
Approximate molecular massAround 750 DaDepends on counter-ion and hydration
Common formsLyophilized powderAlso described as aqueous solution
Primary origin of researchRussian laboratoriesMid-1990s onward

Identity and Structural Background

Naming for this compound is not fully standardised in English sources. The spelling Selanc appears in some transliterations, and catalogue entries may instead list the peptide sequence itself as the identifier. Reference material sometimes groups it with other short synthetic peptides studied for behavioural effects, which can create confusion when citations are compared. Distinguishing the exact sequence from related tuftsin analogues is therefore a practical first step when reviewing any dataset or specification sheet.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.

Related pages on this site

Analytical Methods and Stability

Handling follows standard practice for research peptides. Material is weighed in a low-humidity environment because the powder absorbs atmospheric moisture. Purity is reported as the percentage area of the main peak in a chromatogram, with specifications commonly set at 95 percent or higher; values below that threshold indicate the presence of truncated or modified species. Residual trifluoroacetate from purification is often present and may affect mass balance. Certificates of analysis should state the analytical method, the column and gradient used, and the lot-specific retention time so that results can be compared across suppliers.

Identity and purity of selank are established with reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The peptide elutes from C18 columns with acetonitrile gradients in water containing trifluoroacetic acid or formic acid, and detection is usually performed by ultraviolet absorbance near 214 nm. Electrospray ionization in positive mode gives a doubly protonated ion near m/z 377, consistent with a mass of about 752 Da. Amino acid analysis or tandem mass spectrometry of fragment ions confirms the sequence. Because the molecule has no aromatic residues, it lacks a usable 280 nm chromophore, so low-wavelength detection or mass spectrometry is required.

Mechanism and Evidence Base

Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.

Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.

Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.

Peptide Identity and Structure

Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.

Supporting material

=== Alleged conflict of interest === In September 2026, a Powerus delegation met General Asim Munir and a MoU was signed between the Pakistan Army and the Trump-family backed drone maker while the company was due to merge with Aureus Greenway Holdings linked to Eric Trump and Donald Trump Jr. However, Andrew Fox, Powerus' founder, denied that "the company's growth was linked to the involvement of Trump's sons."

GSK was fined for promoting Paxil/Seroxat (paroxetine) for treating depression in the under-18s, although the drug had not been approved for pediatric use. Paxil had US$4.97 billion worldwide sales in 2003. The company conducted nine clinical trials between 1994, and 2002, none of which showed that Paxil helped children with depression. From 1998, to 2003, it promoted the drug for the under-18s, paying physicians to go on all-expenses paid trips, five-star hotels and spas. From 2004, Paxil's label, along with those of similar drugs, included an FDA-mandated boxed warning that it might increase the risk of suicidal ideation and behaviour in patients under 18. An internal SmithKline Beecham document said in 1998, about withheld data from two GSK studies: "It would be commercially unacceptable to include a statement that [pediatric] efficacy had not been demonstrated, as this would undermine the profile of paroxetine." The company ghostwrote an article, published in 2001, in the Journal of the American Academy of Child and Adolescent Psychiatry, that misreported the results of one of its clinical trials, Study 329. The article concluded that Paxil was "generally well tolerated and effective for major depression in adolescents." The suppression of the research findings is the subject of the 2008 book Side Effects by Alison Bass. For 10 years GSK marketed Paxil as non-habit forming.

The high cost of many laboratory robots has inhibited their adoption. However, currently there are many robotic devices that have very low cost, and these could be employed to do some jobs in a laboratory. For example, a low-cost robotic arm was employed to perform several different kinds of water analysis, without loss of performance compared to much more expensive autosamplers. Alternatively, the autosampler of a device can be used with another device, thus avoiding the need for purchasing a different autosampler or hiring a technician for doing the job. The key aspects to achieve low-cost in laboratory robotics are 1) the use of low-cost robots, which become more and more common, and 2) the use of scripting, which enables compatibility between robots and other analytical equipment.

== Side effects == Severe toxicity can occur with small increments above the therapeutic dose including cardiotoxicity, and fatal overdoses. This is especially true when the drug is combined with alcohol. Other side effects include:

Sources: en.wikipedia.org

Supporting material

=== Environmental pollution === Considering the complex interactions between humans, animals and the environment, it is also important to consider the environmental aspects and contributors to antimicrobial resistance. One of these factors is human and hospital waste, which is a substantial contributor to environmental antimicrobial resistance (AMR). It is estimated that around 50–80% of antibiotics are passed unmetabolized in urine and 4–30% in feces, causing large quantities of active antibiotics to enter sewage systems. Sewage environments contain high levels of antimicrobial-resistant bacteria (ARB), antimicrobial resistance genes (ARGs), and mobile genetic elements such as plasmids, which enable rapid gene exchange. Wastewater treatment plants (WWTPs) are typically not designed to remove AMR; in some cases, multidrug-resistant species such as Escherichia, Shigella, and Klebsiella can increase twofold in treated wastewater. Methicillin-resistant Staphylococcus aureus (MRSA) has also been detected in both raw and treated sewage. Agriculture is also a major contributor to environmental AMR. Manure from livestock (such as cattle, sheep, etc.) contains residual antibiotics, which enter the soil as farmers usually use it as fertilizer. These are typically at levels of 1–10 mg/kg, and also contain ARBs and ARGs. One megaton of antibiotics has been estimated to have entered global soils through manure application. Pathogens can survive in soil for up to 10 years and on plant surfaces for up to 1 year, thereby enabling long-term environmental continuation of AMR.

In response to ecosystem disturbances, some sites have utilized earthworms to prepare soil for the return of native flora. Research from the Station d'écologie Tropicale de Lamto (Ivory Coast) asserts that the earthworms positively influence the rate of macroaggregate formation (Soil structure#Granular|granular structure), an important feature for soil structure. The stability of aggregates in response to water was also found to be improved when constructed by earthworms. Though not fully quantified yet, greenhouse gas emissions (carbon dioxide, nitrous oxide, methane) of earthworms, direct or mediated by their strong influence on soil microbial communities, likely contribute to global warming, especially since top-dwelling earthworms increase the speed of carbon cycles and have been spread by humans into many new geographies.

== Chemistry == This colorless, water-soluble solid is a derivative of pyridine, with a carboxyl group (COOH) at the 3-position. Other forms of vitamin B3 include the corresponding amide nicotinamide, where the carboxyl group has been replaced by a carboxamide group (CONH2).

== Properties == Agarose is available as a white powder which dissolves in near-boiling water, and forms a gel when it cools. Agarose exhibits the phenomenon of thermal hysteresis in its liquid-to-gel transition, i.e. it gels and melts at different temperatures. The gelling and melting temperatures vary depending on the type of agarose. Standard agaroses derived from Gelidium has a gelling temperature of 34–38 °C (93–100 °F) and a melting temperature of 90–95 °C (194–203 °F), while those derived from Gracilaria, due to its higher methoxy substituents, has a gelling temperature of 40–52 °C (104–126 °F) and melting temperature of 85–90 °C (185–194 °F). The melting and gelling temperatures may be dependent on the concentration of the gel, particularly at low gel concentration of less than 1%. The gelling and melting temperatures are therefore given at a specified agarose concentration. Natural agarose contains uncharged methyl groups and the extent of methylation is directly proportional to the gelling temperature. Synthetic methylation however have the reverse effect, whereby increased methylation lowers the gelling temperature. A variety of chemically modified agaroses with different melting and gelling temperatures are available through chemical modifications. The agarose in the gel forms a meshwork that contains pores, and the size of the pores depends on the concentration of agarose added. On standing, the agarose gels are prone to syneresis (extrusion of water through the gel surface), but the process is slow enough to not interfere with the use of the gel.

Computational chemistry is simplest in gas-phase chemistry, in which interactions between molecules may be ignored as negligible. Multiple authors have researched dubnium pentachloride; calculations show it to be consistent with the periodic laws by exhibiting the properties of a compound of a group 5 element. For example, the molecular orbital levels indicate that dubnium uses three 6d electron levels as expected. Compared to its tantalum analog, dubnium pentachloride is expected to show increased covalent character: a decrease in the effective charge on an atom and an increase in the overlap population (between orbitals of dubnium and chlorine). Calculations of solution chemistry indicate that the maximum oxidation state of dubnium, +5, will be more stable than those of niobium and tantalum and the +3 and +4 states will be less stable. The tendency towards hydrolysis of cations with the highest oxidation state should continue to decrease within group 5 but is still expected to be quite rapid. Complexation of dubnium is expected to follow group 5 trends in its richness. Calculations for hydroxo-chlorido- complexes have shown a reversal in the trends of complex formation and extraction of group 5 elements, with dubnium being more prone to do so than tantalum.

Sources: en.wikipedia.org

Supporting material

The United States accused Maduro of electoral fraud and presiding over a "narco-state". In March 2020, during Trump's first term, the United States Justice Department indicted Maduro on cocaine-trafficking conspiracy charges, which Maduro denied. Trump designated two Venezuelan drug gangs, the Tren de Aragua and the Cartel of the Suns, as Foreign Terrorist Organizations (FTOs) in January and July 2025 respectively, and alleged that the latter was led by Maduro. Maduro denied being involved in cartel leadership and characterized the designations as an attempt to use the war on drugs for regime change. Some Latin American crime experts have described the Cartel of the Suns as more of a general network of Venezuelan government and military corruption than as an organized group. Also in July 2025, a secret order instructed the US military to use force against cartels listed as terrorist organizations. In August 2025, the reward for Maduro's arrest increased to $50 million with US attorney general Pam Bondi calling Maduro "one of the largest narco-traffickers in the world and a threat to our national security." However, the Associated Press reported in January 2026 that while the US government has never publicly accused Delcy Rodríguez of criminal wrongdoing related to the drug trade, the Drug Enforcement Administration has nonetheless gathered an extensive intelligence file on Rodríguez since 2018 and designated her as a "priority target" in 2022—which the agency does for individuals suspected of having "significant impact" on the drug trade.

=== Coal === Coal is a more traditional precursor to alkanes. A wide range of technologies have been intensively practiced for centuries. Simply heating coal gives alkanes, leaving behind coke. Relevant technologies include the Bergius process and coal liquefaction. Partial combustion of coal and related solid organic compounds generates carbon monoxide, which can be hydrogenated using the Fischer–Tropsch process. This technology allows the synthesis of liquid hydrocarbons, including alkanes. This method is used to produce substitutes for petroleum distillates.

== Deterministic versus stochastic epidemic models == The deterministic models presented here are valid only in case of sufficiently large populations, and as such should be used cautiously. These models are only valid in the thermodynamic limit, where the population is effectively infinite. In stochastic models, the long-time endemic equilibrium derived above, does not hold, as there is a finite probability that the number of infected individuals drops below one in a system. In a true system then, the pathogen may not propagate, as no host will be infected. But, in deterministic mean-field models, the number of infected can take on real, namely, non-integer values of infected hosts, and the number of hosts in the model can be less than one, but more than zero, thereby allowing the pathogen in the model to propagate. The reliability of compartmental models is limited to compartmental applications. One of the possible extensions of mean-field models considers the spreading of epidemics on a network based on percolation theory concepts. Stochastic epidemic models have been studied on different networks and more recently applied to the COVID-19 pandemic.

=== October === 1 October – John Braggins, botanist and bryologist (University of Auckland, Auckland War Memorial Museum) (born 1944). 2 October – Mac Gardner, clinical geneticist (University of Otago, University of Melbourne) (born 1942). 4 October – Gordon Keys, atmospheric scientist (DSIR, NIWA), Royal Society of New Zealand Science and Technology Silver Medal (1995) (born 1930). 6 October – Margaret, Lady Liley, paediatrician, general practitioner and farmer (born 1928). 7 October – Graham Bell, police officer and television presenter (Police Ten 7) (born 1946). 8 October – Wally Yovich, businessman, local politician and philanthropist, Whangārei District Councillor (1989–1995) (born 1939). 9 October – Cliff Tait, aviator, politician and writer, Hamilton City Councillor (1992–1995) (born 1929). 10 October – Roger Harris, cricketer (Auckland, national team) (born 1933). 11 October – Richard Nottage, diplomat and public servant, ambassador to Indonesia (1980–1982) and Japan (1987–1988), permanent representative to the UN in Geneva (1984–1987), Secretary of Foreign Affairs and Trade (1991–1999) (born 1939). 15 October – Jim Bolger, politician, MP for King Country (1975–1996) and Taranaki-King Country (1996–1998), Minister of Labour (1978–1984), leader of the National Party (1986–1997), Prime Minister (1990–1997), Ambassador to the United States (1998–2002), chancellor of the University of Waikato (2007–2019), Privy Counsellor (since 1991), Member of the Order of New Zealand (since 1997) (born 1935). 20 October – So You Think, Hall of Fame Thoroughbred racehorse, W. S.

Moreover, the moment a racemic therapeutic is placed in a biological system, a chiral environment, it is no more 50:50 due enantioselective absorption, distribution, metabolism, and elimination (ADME) process. Hence to track the individual enantiomeric profile there is a need for chiral analysis tool. Chiral technology is an active subject matter related to asymmetric synthesis and enantioselective analysis, particularly in the area of chiral chromatography. As a consequence of the advances in chiral technology, a number of pharmaceuticals currently marketed as racemic drugs are undergoing re-assessment as chiral specific products or chiral switches. Despite the choice to foster either a single enantiomer or racemic drug, in the current regulatory environment, there will be a need for enantioselective investigations. This poses a big challenge to pharmaceutical analysts and chromatographers involved in drug development process. In pharmaceutical research and development stereochemical analytical methodology may be required to comprehend enantioselective drug action and disposition, chiral purity assessment, study stereochemical stability during formulation and production, assess dosage forms, enantiospecific bioavailability and bioequivalence investigations of chiral drugs. Besides pharmaceutical applications chiral analysis plays a major role in the study of biological and environmental samples and also in the forensic field. Chiral analysis methods and applications between the period 2010 and 2020 are exhaustively reviewed recently.

Sources: en.wikipedia.org

Frequently asked questions

What type of molecule is Selank?

Selank is a synthetic peptide made of seven amino acids. It is modeled on tuftsin, a natural tetrapeptide, with an added three-residue tail. It is not a small-molecule drug.

Where was Selank developed?

It originates from research in Russia, associated with the Institute of Molecular Genetics of the Russian Academy of Sciences. The first descriptions date to the mid-1990s. Most published studies come from Russian laboratories.

Is Selank found in nature?

No, Selank itself does not occur naturally. Its backbone is based on tuftsin, which is produced in the body, but the seven-residue version is a synthetic construct. It is supplied as a manufactured peptide.

How is the peptide typically administered in studies?

Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.

Network